CN108686094A - A kind of Traditional Chinese medicine for decreasing blood sugar and preparation method thereof - Google Patents

A kind of Traditional Chinese medicine for decreasing blood sugar and preparation method thereof Download PDF

Info

Publication number
CN108686094A
CN108686094A CN201810814177.3A CN201810814177A CN108686094A CN 108686094 A CN108686094 A CN 108686094A CN 201810814177 A CN201810814177 A CN 201810814177A CN 108686094 A CN108686094 A CN 108686094A
Authority
CN
China
Prior art keywords
parts
chinese medicine
traditional chinese
blood sugar
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201810814177.3A
Other languages
Chinese (zh)
Other versions
CN108686094B (en
Inventor
阴永辉
陈玉敏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Affiliated Hospital of Shandong University of Traditional Chinese Medicine
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201810814177.3A priority Critical patent/CN108686094B/en
Publication of CN108686094A publication Critical patent/CN108686094A/en
Application granted granted Critical
Publication of CN108686094B publication Critical patent/CN108686094B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481Astragalus (milkvetch)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/07Basidiomycota, e.g. Cryptococcus
    • A61K36/076Poria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232Angelica
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/236Ligusticum (licorice-root)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/284Atractylodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/285Aucklandia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/37Celastraceae (Staff-tree or Bittersweet family), e.g. tripterygium or spindletree
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484Glycyrrhiza (licorice)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/488Pueraria (kudzu)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/532Agastache, e.g. giant hyssop
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537Salvia (sage)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/57Magnoliaceae (Magnolia family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/60Moraceae (Mulberry family), e.g. breadfruit or fig
    • A61K36/605Morus (mulberry)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/65Paeoniaceae (Peony family), e.g. Chinese peony
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/71Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/71Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/718Coptis (goldthread)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/79Schisandraceae (Schisandra family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/80Scrophulariaceae (Figwort family)
    • A61K36/804Rehmannia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/894Dioscoreaceae (Yam family)
    • A61K36/8945Dioscorea, e.g. yam, Chinese yam or water yam
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8968Ophiopogon (Lilyturf)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/39Complex extraction schemes, e.g. fractionation or repeated extraction steps

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

本发明涉及医药技术领域,特别公开了一种降血糖的中药及其制备方法。该降血糖的中药,以黄芪、当归、葛根、茯苓、白术、木香、藿香、山药、桑叶、马齿苋、鬼箭羽、黄连、丹参、赤芍、川芎、熟地黄、麦门冬、五味子和甘草为原料,按照一定的重量配比混合制成。本发明原料药材均采用天然的中药原料,其配置简便,药源广泛,成本低廉,其遵循中医的处方用药原则,诸药合用,相得益彰。The invention relates to the technical field of medicine, and particularly discloses a traditional Chinese medicine for lowering blood sugar and a preparation method thereof. The traditional Chinese medicine for lowering blood sugar includes astragalus, angelica, kudzu root, poria cocos, Atractylodes macrocephala, woody incense, Huoxiang, yam, mulberry leaves, purslane, ghost arrow feather, berberine, salvia miltiorrhiza, red peony root, chuanxiong, rehmannia glutinosa, Maimen Winter, schisandra and licorice are used as raw materials and mixed according to a certain weight ratio. The raw materials and medicinal materials of the present invention all adopt natural traditional Chinese medicine raw materials, which have the advantages of simple configuration, wide range of drug sources and low cost, and follow the prescription and medication principles of traditional Chinese medicine, and all the drugs are used together to complement each other.

Description

一种降血糖的中药及其制备方法A kind of traditional Chinese medicine for lowering blood sugar and preparation method thereof

(一)技术领域(1) Technical field

本发明涉及医药技术领域,特别涉及一种降血糖的中药及其制备方法。The invention relates to the technical field of medicine, in particular to a traditional Chinese medicine for lowering blood sugar and a preparation method thereof.

(二)背景技术(2) Background technology

中国2型糖尿病发病率在过去30年内猛增,已成为公众主要健康威胁之一。柳叶刀《Lancet Diabetes &Endocrinology》杂志曾在线连续发表三篇关注中国糖尿病的系列文章,称中国目前有超过1亿的人口患有糖尿病,该数字远远超过世界上的其他国家。据国际糖尿病联合会(IDF)统计,现中国糖尿病患者位居世界首位。2015年我国有130万人死于糖尿病及其并发症,其中40.8%的人年龄低于60岁,逐渐呈现年轻化趋势。IDF预测到2040年,全球将会有6.42亿人患有糖尿病,而中国糖尿病患者将达到1.51亿。The incidence of type 2 diabetes in China has increased sharply in the past 30 years, and it has become one of the major public health threats. The Lancet Diabetes & Endocrinology magazine once published three series of articles focusing on China's diabetes online, saying that there are currently more than 100 million people in China suffering from diabetes, which is far more than other countries in the world. According to the statistics of the International Diabetes Federation (IDF), the number of diabetic patients in China ranks first in the world. In 2015, 1.3 million people died of diabetes and its complications in my country, and 40.8% of them were younger than 60 years old, gradually showing a younger trend. IDF predicts that by 2040, there will be 642 million people with diabetes in the world, and 151 million people with diabetes in China.

面对如此庞大的患者群及由糖尿病及其并发症所带来的危害,医生们尝试各种治疗方法来治疗和减缓患者病情及痛苦。中医学是有记载治疗糖尿病最早的医学之一,翻阅古籍,根据其临床症状,可被划为“消渴”“脾瘅”等范畴。早在《黄帝内经》时代便有提及。时至今日,经过千百年来的繁衍、洗礼和不断实践总结,中医已经积累了丰富的临床经验,继续为人类健康保驾护航。Faced with such a huge patient group and the harm caused by diabetes and its complications, doctors try various treatment methods to treat and alleviate the patient's condition and pain. Traditional Chinese medicine is one of the earliest recorded medicines for the treatment of diabetes. Looking through ancient books, according to its clinical symptoms, it can be classified into categories such as "diabetes" and "spleen rash". It was mentioned as early as the "Huangdi Neijing" era. Today, after thousands of years of reproduction, baptism and continuous practice and summary, Chinese medicine has accumulated rich clinical experience and continues to escort human health.

糖尿病我国医学称为“消渴病”。消渴病病变脏腑主要在肺、脾、肾,三脏互相影响,主要以气虚为本,血瘀为标。《素问·阴阳应象大论》言:“治病必求于本”,治病求本是整体观念与辨证论治在治疗观中的体现,是中医学治疗的主导思想。气虚血瘀是糖尿病的主要病机,故治疗应兼顾“气虚”与“血瘀”。“益气”,一则气旺能生血,二则气行则血行,为治本之法;“活血”则瘀除血脉得通,新血得生,为治标之法。补气不化瘀,则瘀血不去,生化乏源,效不持久;化瘀不益气,则气虚无力行血,旧瘀难去,新血难生。清·王清任《医林改错》:“气通而不滞,血活而不瘀,气通血活,何患疾病不除。”Diabetes is called "diabetes disease" in Chinese medicine. Diabetes disease mainly affects the lungs, spleen, and kidneys, and the three viscera interact with each other, mainly based on qi deficiency and blood stasis as the standard. "Suwen·Yin and Yang Yingxiang Dalun" says: "Treating a disease must be based on the root." Seeking the root of a disease is the embodiment of the overall concept and syndrome differentiation and treatment in the treatment concept, and it is the leading idea of TCM treatment. Qi deficiency and blood stasis are the main pathogenesis of diabetes, so the treatment should take into account both "qi deficiency" and "blood stasis". "Supplementing qi", one is to generate blood when the qi is strong, and the other is to promote the flow of qi and blood, which is the method for treating the root cause; Invigorating qi without dispelling blood stasis means that the blood stasis will not go away, the source of biochemistry will be exhausted, and the effect will not last long; if dispelling stasis and replenishing qi, then the qi will be deficient and unable to promote blood circulation, and the old blood stasis will be difficult to remove, and new blood will be difficult to produce. Qing Wang Qingren's "Yielin Gaicuo": "Qi is unobstructed but not stagnant, blood is activated but not stagnant, Qi is unblocked and blood is activated, and any disease will not be cured."

由此可知治疗糖尿病益气同时,必须与活血化瘀同步进行,方能奏效。It can be seen from this that the treatment of diabetes must be carried out simultaneously with promoting blood circulation and removing blood stasis in order to be effective.

(三)发明内容(3) Contents of the invention

本发明为了弥补现有技术的不足,提供了一种工艺简单、成本低廉、效果显著的降血糖的中药及其制备方法。In order to make up for the deficiencies of the prior art, the invention provides a traditional Chinese medicine for lowering blood sugar with simple process, low cost and remarkable effect and a preparation method thereof.

本发明是通过如下技术方案实现的:The present invention is achieved through the following technical solutions:

一种降血糖的中药,由以下重量份数的原料混合制成:黄芪30-50份、当归15-25份、葛根15-25份、茯苓15-25份、白术15-25份、木香6-15份、藿香15-25份、山药15-25份、桑叶20-40份、马齿苋15-25份、鬼箭羽15-25份、黄连8-12份、丹参15-25份、赤芍15-25份、川芎15-25份、熟地黄15-25份、麦门冬15-25份、五味子6-15份、甘草8-12份。A traditional Chinese medicine for lowering blood sugar, which is prepared by mixing the following raw materials in parts by weight: 30-50 parts of astragalus, 15-25 parts of angelica, 15-25 parts of kudzu root, 15-25 parts of poria cocos, 15-25 parts of atractylodes rhizome, 6-15 parts, 15-25 parts of Huoxiang, 15-25 parts of Chinese yam, 20-40 parts of mulberry leaves, 15-25 parts of purslane, 15-25 parts of ghost arrow feather, 8-12 parts of Coptis chinensis, 15- 25 parts, 15-25 parts of red peony, 15-25 parts of Chuanxiong, 15-25 parts of Rehmannia glutinosa, 15-25 parts of Ophiopogon japonicus, 6-15 parts of Schisandra, and 8-12 parts of licorice.

其优选的重量配比为:Its preferred weight ratio is:

黄芪30-50份、当归15-25份、葛根15-25份、茯苓15-25份、白术15-25份、木香6-15份、藿香15-25份、山药15-25份、桑叶20-40份、马齿苋15-25份、鬼箭羽15-25份、黄连8-12份、丹参15-25份、赤芍15-25份、川芎15-25份、熟地黄15-25份、麦门冬15-25份、五味子6-15份、甘草8-12份。Astragalus 30-50 parts, Angelica 15-25 parts, Pueraria 15-25 parts, Poria cocos 15-25 parts, Atractylodes macrocephala 15-25 parts, Woody 6-15 parts, Huoxiang 15-25 parts, Chinese yam 15-25 parts, 20-40 parts of mulberry leaves, 15-25 parts of purslane, 15-25 parts of ghost arrow feather, 8-12 parts of berberine, 15-25 parts of salvia miltiorrhiza, 15-25 parts of red peony, 15-25 parts of chuanxiong, rehmannia glutinosa 15-25 parts, Ophiopogon japonicus 15-25 parts, Schisandra 6-15 parts, licorice 8-12 parts.

本发明所述中药为胶囊剂。服用方式为口服,一日三次,饭前半小时服用,每次0.5g,两周为一个疗程。The traditional Chinese medicine of the present invention is a capsule. The way of taking is oral, three times a day, half an hour before meals, 0.5g each time, two weeks as a course of treatment.

本发明通过对传统中药的研究,并结合辩证论证,多方收集众家之长,寻求最佳治疗方案,按中医理论组方,采用纯天然中药原料,经系统研究、科学配伍,应用黄芪当归,配伍健脾生津止渴的葛根,清肝润燥止消渴的桑叶来治疗气虚血瘀型糖尿病,效果显著;再结合传统中医技术精心配制成本发明的降血糖的中药,对糖尿病有较佳的功效。Through the study of traditional Chinese medicine, combined with dialectical argumentation, the present invention collects the strengths of various schools, seeks the best treatment plan, formulates the prescription according to the theory of traditional Chinese medicine, adopts pure natural Chinese medicine raw materials, and uses Astragalus angelica through systematic research and scientific compatibility. Compatible with kudzu root for invigorating the spleen, promoting body fluid and quenching thirst, and mulberry leaves for clearing liver, moistening dryness and quenching thirst to treat qi deficiency and blood stasis type diabetes, the effect is remarkable; combined with traditional Chinese medicine technology, the Chinese medicine for lowering blood sugar of this invention is carefully prepared, which has better effect on diabetes effect.

上述降血糖的中药的制备方法,包括如下步骤:The preparation method of the above-mentioned Chinese medicine for lowering blood sugar comprises the following steps:

(1)分别称取各原料药,备用;(1) Weigh each API separately and set aside;

(2)取党参、五味子、葛根、木香、藿香、山药、马齿苋、丹参、赤芍、熟地黄混合均匀,加水煎煮两次,过滤收集滤液后合并两次滤液,冷却后浓缩成浸膏,再烘干后粉碎成粉末,得复合物A;(2) Take Codonopsis pilosula, Schisandra chinensis, kudzu root, woody fragrance, Huoxiang, yam, purslane, salvia miltiorrhiza, red peony root, rehmannia glutinosa, mix evenly, add water to decoct twice, collect the filtrate by filtration, combine the two filtrates, cool and concentrate into extract, then dried and pulverized into powder to obtain compound A;

(3)取黄芪、当归、麦冬、桑叶、茯苓、白术、鬼箭羽、黄连、川芎、甘草,加乙醇浸泡,提取两次,合并提取液,滤过、浓缩成浸膏,干燥后粉碎,得复合物B;(3) Take Astragalus, Angelica, Ophiopogon japonicus, Mulberry leaves, Poria cocos, Atractylodes macrocephala, Guijianyu, Coptis chinensis, Chuanxiong, and licorice, soak them in ethanol, extract twice, combine the extracts, filter, concentrate into an extract, and dry Pulverize to obtain compound B;

(4)将复合物A和复合物B混合均匀,灭菌消毒制得胶囊剂产品。(4) Mix compound A and compound B evenly, and sterilize to obtain a capsule product.

本发明的更优技术方案为:The more optimal technical scheme of the present invention is:

步骤(2)中,两次煎煮中,第一次加3倍重量的水武火煮沸,然后文火煎煮1小时,过滤收集滤液和滤渣;往滤渣中添加水,以没过滤渣为准,武火煮沸,然后文火煎煮30分钟,过滤收集滤液。In step (2), in the two decoctions, add 3 times the weight of water for the first time to boil with high heat, then decoct with slow fire for 1 hour, filter and collect the filtrate and filter residue; add water to the filter residue, subject to the absence of filter residue, Boil with strong fire, then simmer for 30 minutes, and collect the filtrate by filtration.

滤液冷却后浓缩成密度为1.1-1.2g/mL的浸膏,80℃下烘干后,粉碎成粉末,得复合物A。After cooling, the filtrate is concentrated into an extract with a density of 1.1-1.2 g/mL, dried at 80°C, and crushed into powder to obtain Compound A.

步骤(3)中,加质量浓度70%的乙醇浸泡0.5-1.5小时,提取两次,每次1-2小时,合并提取液。In step (3), soak in ethanol with a mass concentration of 70% for 0.5-1.5 hours, extract twice for 1-2 hours each time, and combine the extracts.

浸膏的相对密度为1.2。The relative density of the extract is 1.2.

本发明药物中,君药为黄芪、当归、葛根、桑叶。黄芪甘温升发,功擅补气,为“补药之长”。本品能补益三焦,表里脏腑诸气。黄芪的特点是气薄、质轻而善走,所以除补益之外,还兼有蕴通行之功。所以《名医别录》中指出“逐五脏间恶血”。当归味辛、苦、甘、微温,具有补血活血、调经止痛的功效。历朝历代对于当归的论述有很多,比如《药性论》中提到当归具有“破宿血”之力。葛根味干、辛,性凉,归肺、胃经,始载于《神农本草经》,具有解肌退热、生津止渴、升阳止泻之功效,是临床应用较为广泛的一种中药。动物研究发现,葛根素可有效提高糖尿病小鼠胰岛素敏感性、抑制胰岛素抵抗,对于降低血糖水平以及改善糖耐量具有重要作用,在糖尿病治疗中具有积极作用。桑叶为桑科植物桑Morus alba L.的干燥叶,始载于《神农本草经》,中医又称“神仙草”“铁扇子”。其味苦、甘,性寒,具有疏散风热,清肺润燥,清肝明目的功效,可用于风热感冒,肺热燥咳,头晕头痛,目赤昏花。《本草纲目》记载:“桑叶乃手足阳明之药,汁煎代茗,能止消渴,明目长发”。现代研究表明桑叶具有降血糖、降血压、降血脂、抗衰老等药理作用。近年来,桑叶的降血糖作用备受关注,其防治糖尿病的功效得到广泛认可。Among the medicines of the present invention, the monarch medicines are astragalus, angelica, kudzu root and mulberry leaves. Astragalus membranaceus is sweet and warm, and it is good at invigorating qi, which is "the strength of tonic". This product can invigorate the triple burner, externally and internally viscera and all qi. Astragalus is characterized by thin qi, light weight and good walking, so in addition to tonifying, it also has the power of traveling. Therefore, it is pointed out in "Bielu of Famous Doctors" to "drive away the bad blood between the five internal organs". Angelica is pungent, bitter, sweet, and slightly warm, and has the effects of nourishing blood, promoting blood circulation, regulating menstruation and relieving pain. There are many discussions about angelica in the past dynasties. For example, it is mentioned in "On the Nature of Medicine" that angelica has the power of "breaking blood". Pueraria lobata is dry, pungent, cool in nature, and belongs to the lung and stomach meridians. It was first recorded in "Shen Nong's Materia Medica". . Animal studies have found that puerarin can effectively improve insulin sensitivity and inhibit insulin resistance in diabetic mice, play an important role in reducing blood sugar levels and improving glucose tolerance, and play a positive role in the treatment of diabetes. Mulberry leaves are the dry leaves of Morus alba L., a plant of the family Moraceae, which was first recorded in "Shen Nong's Herbal Classic", and is also known as "immortal grass" and "iron fan" in traditional Chinese medicine. It tastes bitter, sweet, and cold in nature. It has the effects of dispelling wind-heat, clearing lung and moistening dryness, clearing liver and improving eyesight. "Compendium of Materia Medica" records: "Mulberry leaves are the medicine of Yangming of the hands and feet, and the juice is decocted instead of tea, which can relieve thirst, improve eyesight and grow hair." Modern studies have shown that mulberry leaves have pharmacological effects such as lowering blood sugar, lowering blood pressure, lowering blood fat, and anti-aging. In recent years, the hypoglycemic effect of mulberry leaves has attracted much attention, and its efficacy in preventing and treating diabetes has been widely recognized.

另外,前期对黄芪当归主要成分黄芪甲苷阿魏酸的糖尿病大鼠实验结果显示黄芪甲苷阿魏酸组血糖下降较为明显。临床应用黄芪当归,配伍健脾生津止渴的葛根,清肝润燥止消渴的桑叶来治疗气虚血瘀型糖尿病,效果显著。In addition, the results of previous experiments on diabetic rats with astragaloside IV ferulic acid, the main component of Astragaloside IV ferulic acid, showed that the blood sugar in the astragaloside IV ferulic acid group decreased significantly. Clinical application of astragalus and angelica, combined with kudzu root for invigorating the spleen, promoting body fluid and quenching thirst, and mulberry leaves for clearing liver, moistening dryness and quenching thirst, to treat diabetes with qi deficiency and blood stasis, and the effect is remarkable.

茯苓、白术、木香、藿香、山药为臣药,共奏健脾益气之功。佐以黄连健脾燥湿,清胃火,因为血瘀贯穿糖尿病始终,故佐以丹参、赤芍、川芎活血化瘀。马齿苋、鬼箭羽、熟地黄、麦门冬、五味子、甘草共为使药。Poria cocos, Atractylodes macrocephala, woody fragrance, Huoxiang, and Chinese yam are ministerial medicines, which together play the role of invigorating the spleen and replenishing qi. Coptis chinensis is used to invigorate the spleen and dry dampness, clear stomach fire, and because blood stasis runs through diabetes all the time, it is accompanied by salvia miltiorrhiza, red peony root, and Chuanxiong to promote blood circulation and remove blood stasis. Purslane, Guijianyu, Rehmannia glutinosa, Ophiopogon japonicus, Schisandra chinensis, and licorice are used as envoys.

本发明的中药可采用一般方法将处方中的各位药材按比例进行配伍,按现有制剂工艺制程各种临床适用剂型,所用的各味药材均为市售的经过检验合格的中药材。The traditional Chinese medicine of the present invention can adopt general method to carry out compatibility of each medicinal material in the prescription in proportion, according to the existing preparation technology process various clinically applicable dosage forms, and the various medicinal materials used are commercially available Chinese medicinal materials that have passed the inspection.

本发明原料药材均采用天然的中药原料,其配置简便,药源广泛,成本低廉,其遵循中医的处方用药原则,诸药合用,相得益彰,且制剂服用量小,药物有效成分易于释放,吸收快,生物利用度高,使药效能够充分挥发,经临床应用验证,其疗效显著可靠,药性平和,未出现毒副作用,应用前景广阔。The raw materials and medicinal materials of the present invention all adopt natural traditional Chinese medicine raw materials, which are easy to configure, have a wide range of drug sources, and are low in cost. They follow the principles of prescription medication in traditional Chinese medicine, and all medicines are combined to complement each other. The dosage of the preparation is small, and the active ingredients of the drug are easy to release and absorb quickly. , high bioavailability, so that the drug effect can be fully volatilized. It has been verified by clinical application that its curative effect is significant and reliable, the drug property is mild, and there is no toxic and side effect, and the application prospect is broad.

服药期间忌食辛辣及寒凉食物,避免情志刺激,生活要有规律。Avoid spicy and cold food while taking the medicine, avoid emotional stimulation, and have a regular life.

本发明的有益效果在于:The beneficial effects of the present invention are:

(1)药剂由纯中药制成,各组分复合药典法相关规定,利用各味中药的配伍作用,不含化工成分,不含激素,无毒副作用,标本兼治,达到更好的降血糖的作用;(1) The medicament is made of pure Chinese medicine, and each component is compounded according to the relevant regulations of the Pharmacopoeia Law. Using the compatibility of various Chinese medicines, it does not contain chemical ingredients, does not contain hormones, has no toxic and side effects, and treats both symptoms and root causes to achieve a better effect of lowering blood sugar. effect;

(2)疗程短,总有效率高,愈后不易复发;(2) The course of treatment is short, the total effective rate is high, and it is not easy to relapse after healing;

(3)工艺简单,降低了生产成本,减轻了患者的经济负担。(3) The process is simple, the production cost is reduced, and the economic burden of patients is reduced.

(四)具体实施方式(4) Specific implementation methods

下面通过具体的实施例来详尽解释本发明,但是并不作为对本发明内容的限制。The present invention will be explained in detail below through specific examples, but not as a limitation to the content of the present invention.

实施例1:Example 1:

一种降血糖的中药复合物,其由下述原料制备而得,A traditional Chinese medicine compound for lowering blood sugar, which is prepared from the following raw materials,

黄芪30g、当归15g、葛根15g、茯苓15g、白术15g、木香6g、藿香15g、山药15g、桑叶20g、马齿苋15g、鬼箭羽15g、黄连8g、丹参15g、赤芍15g、川芎15g、熟地黄15g、麦门冬15g、五味子6g、甘草8g。Astragalus 30g, Angelica 15g, Pueraria 15g, Poria cocos 15g, Atractylodes macrocephala 15g, Woody 6g, Huoxiang 15g, Chinese yam 15g, Mulberry leaf 20g, Purslane 15g, Ghost arrow feather 15g, Coptis 8g, Salvia miltiorrhiza 15g, Red peony root 15g, Chuanxiong 15g, Rehmannia glutinosa 15g, Ophiopogon japonicus 15g, Schisandra 6g, licorice 8g.

上述降血糖的中药复合物的制备方法为:取上述重量份的原料药( 配比单位:克)制备胶囊,具体操作为:The preparation method of the above-mentioned Chinese medicine compound for lowering blood sugar is as follows: take the above-mentioned crude drug (proportion unit: gram) by weight to prepare capsules, and the specific operations are as follows:

1)称取各原料药,备用;1) Take each bulk drug and set aside;

2)取党参、五味子、葛根、木香、藿香、山药、马齿苋、丹参、赤芍、熟地黄混合均匀,加3倍重量的水武火煮沸,然后文火煎煮1小时,过滤收集滤液和滤渣;往滤渣中添加水,以没过滤渣为准,武火煮沸,然后文火煎煮30分钟,过滤收集滤液;合并上述两次滤液,冷却后,浓缩成密度为1.1-1.2g/ml 的浸膏;80℃烘干后,粉碎成粉末,即为复合物A ;2) Take Codonopsis pilosula, Schisandra chinensis, kudzu root, woody fragrance, Huoxiang, yam, purslane, salvia miltiorrhiza, red peony root, rehmannia glutinosa, mix evenly, add 3 times the weight of water to boil, then simmer for 1 hour, filter and collect the filtrate and the filter residue; add water to the filter residue, subject to no filter residue, boil with strong fire, then decoct with slow fire for 30 minutes, filter and collect the filtrate; combine the above two filtrates, after cooling, concentrate to a density of 1.1-1.2g/ml Extract; after drying at 80°C, pulverize into powder, which is compound A;

3)取黄芪、当归、麦冬、桑叶、茯苓、白术、鬼箭羽、黄连、川芎、甘草加70%乙醇浸泡0.5-1.5 小时,提取两次,每次1-2小时,合并提取液,滤过,浓缩成相对密度为1.2的浸膏,干燥后粉碎,得复合物B;3) Soak Astragalus, Angelica, Ophiopogon japonicus, Mulberry leaves, Poria cocos, Atractylodes macrocephala, Guijianyu, Coptis chinensis, Chuanxiong, and licorice plus 70% ethanol for 0.5-1.5 hours, extract twice, each time for 1-2 hours, and combine the extracts , filtered, concentrated into an extract with a relative density of 1.2, dried and pulverized to obtain compound B;

4)将复合物A和复合物B混合搅拌均匀,灭菌消毒制得胶囊剂产品。4) Mix and stir the compound A and the compound B evenly, and sterilize to obtain a capsule product.

服用方式:口服,一日三次,饭前半小时服用,每次0.5g,两周为一个疗程。Mode of administration: oral administration, three times a day, half an hour before meals, 0.5g each time, two weeks as a course of treatment.

实施例2:Example 2:

一种降血糖的中药复合物,其由下述原料制备而得,A traditional Chinese medicine compound for lowering blood sugar, which is prepared from the following raw materials,

黄芪50g、当归25g、葛根25g、茯苓25g、白术25g、木香15g、藿香25g、山药25g、桑叶40g、马齿苋25g、鬼箭羽25g、黄连12g、丹参25g、赤芍25g、川芎25g、熟地黄25g、麦门冬25g、五味子15g、甘草12g。Astragalus 50g, Angelica 25g, Pueraria 25g, Poria cocos 25g, Atractylodes macrocephala 25g, Woody 15g, Huoxiang 25g, Chinese yam 25g, Mulberry leaf 40g, Purslane 25g, Ghost arrow feather 25g, Coptis 12g, Salvia miltiorrhiza 25g, Red peony 25g, Chuanxiong 25g, Rehmannia glutinosa 25g, Ophiopogon japonicus 25g, Schisandra 15g, licorice 12g.

制备及服用方法如实施例1。The preparation and administration methods are as in Example 1.

实施例3:Example 3:

一种降血糖的中药复合物,其由下述原料制备而得,A traditional Chinese medicine compound for lowering blood sugar, which is prepared from the following raw materials,

黄芪40g、当归20g、党参20g、葛根20g、茯苓20g、白术20g、木香10g、藿香20g、山药20g、桑叶30g、马齿苋20g、鬼箭羽20g、黄连10g、丹参20g、赤芍20g、川芎20g、熟地黄20g、麦冬20g、五味子10g、甘草10g。Astragalus 40g, Angelica 20g, Codonopsis 20g, Pueraria 20g, Poria cocos 20g, Atractylodes macrocephala 20g, woody fragrance 10g, Huoxiang 20g, yam 20g, mulberry leaf 30g, purslane 20g, ghost arrow feather 20g, coptis 10g, salvia miltiorrhiza 20g, red Peony 20g, Chuanxiong 20g, Rehmannia glutinosa 20g, Ophiopogon japonicus 20g, Schisandra 10g, licorice 10g.

制备及服用方法如实施例1。The preparation and administration methods are as in Example 1.

实施例4:动物学实验Embodiment 4: zoology experiment

试验流程:Test process:

随机选8周龄SPF级Wistar雄性大鼠90只,由山东大学动物实验室提供,体重200±20g,许可证号为:SCXK(鲁)2013-0009。90 8-week-old SPF grade male Wistar rats were randomly selected, provided by the Animal Laboratory of Shandong University, weighing 200±20g, license number: SCXK (Lu) 2013-0009.

自由进食及饮水,动物房温度控制在温度22-26℃,湿度55%,光照12/24h。适应性饲养1周,血糖均为正常范围内,测量体重。Free to eat and drink, the temperature of the animal room was controlled at 22-26°C, the humidity was 55%, and the light was 12/24h. After adaptive feeding for 1 week, the blood sugar was within the normal range, and the body weight was measured.

随机分为空白组(n=10)和造模组(n=80)。空白组予标准大鼠饲料,造模组予高糖高脂饲料6周,检测空腹血糖(FBG)、甘油三酯(TG)、总胆固醇(TC)、低密度脂蛋白(LDL)、高密度脂蛋白(HDL)。They were randomly divided into blank group (n=10) and modeling group (n=80). The blank group was given standard rat diet, and the model group was given high-sugar and high-fat diet for 6 weeks. Fasting blood glucose (FBG), triglyceride (TG), total cholesterol (TC), low-density lipoprotein (LDL), high-density lipoprotein lipoprotein (HDL).

造模组大鼠高糖高脂饲料喂养6周后禁食12h,予链脲佐菌素(于0℃溶于0.1mol/LpH=4.4的柠檬酸钠缓冲液,终浓度为10mg/mL,按40mg/kg一次性腹腔注射);对照组注射等剂量的缓冲液。72小时后尾静脉采血,连续三次随机血糖≥16.7mmol/L者确定为糖尿病大鼠。Rats in the model group were fed with high-sugar and high-fat diet for 6 weeks, fasted for 12 hours, and then given streptozotocin (dissolved in 0.1mol/L sodium citrate buffer solution with pH=4.4 at 0°C, with a final concentration of 10 mg/mL, One-time intraperitoneal injection at 40 mg/kg); the control group was injected with the same dose of buffer. After 72 hours, blood was collected from the tail vein, and those with random blood glucose ≥ 16.7mmol/L for three consecutive times were identified as diabetic rats.

选取造模成功的大鼠60只,随机分为3组,每组20只,即模型组(不施用任何药物)、本发明实施例3药物组10mg/Kg、对照药物组:施用二甲双胍(10mg/kg),施用方式均为口服,每天早晚饭前半时服用。连续服用两周后检测;停药10 天后再次监测血糖。Choose 60 successful rats of modeling, be divided into 3 groups at random, every group of 20, i.e. model group (do not use any medicine), the embodiment of the present invention 3 medicine group 10mg/Kg, control medicine group: use metformin (10mg /kg), the way of administration is oral, every morning and evening before meals. Test after two weeks of continuous use; monitor blood sugar again after 10 days of drug withdrawal.

经检测:对照药物组和本发明药物组空腹血糖均有明显下降,本发明药物明显好于对照药物组,停药十天后,本发明药物组基本没有出现反弹,具体参见下表。After testing: both the control drug group and the drug group of the present invention had significantly decreased fasting blood sugar, and the drug of the present invention was significantly better than the control drug group. After ten days of drug withdrawal, the drug group of the present invention basically did not rebound, see the table below for details.

实施例5:临床病例Embodiment 5: clinical case

资料与方法:一般资料门诊2型糖尿病属于气虚血瘀型患者共56 例,其中男30例,女26例,患者年龄50-80岁,空腹血糖(FPG)以及餐后2h血糖(2hPG) 均大幅升高。服用本发明实施例3制备的药物两个疗程后,检测上述生化指标。Materials and methods: General information 56 outpatients with type 2 diabetes mellitus belonged to Qi deficiency and blood stasis type, including 30 males and 26 females, aged 50-80 years, fasting blood glucose (FPG) and postprandial 2h blood glucose (2hPG) were both significantly increased. After taking the medicine prepared in Example 3 of the present invention for two courses of treatment, the above biochemical indicators were detected.

治愈:FPG<6.1mmol/L,2h血糖(2hPG)<8.0mmol/L;Cure: FPG<6.1mmol/L, 2h blood glucose (2hPG)<8.0mmol/L;

有效:空腹血糖(FPG)、餐后2h血糖(2hPG)有所改善,但未达到正常水平;Effective: Fasting blood glucose (FPG) and postprandial 2h blood glucose (2hPG) have improved, but have not reached normal levels;

无效:空腹血糖(FPG)、餐后2h 血糖(2hPG) 均无明显改变。Ineffective: Fasting blood glucose (FPG) and postprandial 2h blood glucose (2hPG) had no significant changes.

治疗效果:治愈43例,有效12例,无效1例,总有效率为98%。Treatment effect: 43 cases were cured, 12 cases were effective, and 1 case was ineffective. The total effective rate was 98%.

实施例6:典型病例Embodiment 6: typical case

林某某,女,53岁,面色淡白,身倦乏力,气少懒言,口干多饮,气短、自汗,动则加重,心烦,视物模糊。舌暗红,苔薄白少津,舌边有齿痕,脉沉细。空腹血糖10.8mmol/L,餐后2h血糖14.0mmol/L,诊断为2型糖尿病。给予实施例3的中药复合物,服用2个疗程后,症状减轻,继续服用1个疗程巩固,空腹血糖小于7.0mmol/L。半年后追访,血糖值正常。Lin Moumou, female, 53 years old, pale complexion, tired body, lack of breath, lazy speech, dry mouth, excessive drinking, shortness of breath, spontaneous sweating, aggravated by movement, upset, blurred vision. The tongue is dark red, the fur is thin and white and there is little fluid, there are tooth marks on the edge of the tongue, and the pulse is thready. Fasting blood glucose 10.8mmol/L, 2h postprandial blood glucose 14.0mmol/L, diagnosed as type 2 diabetes. Give the traditional Chinese medicine compound of embodiment 3, after taking 2 courses of treatment, symptom alleviates, continues to take 1 course of treatment and consolidates, and fasting blood sugar is less than 7.0mmol/L. Follow-up visit after half a year, blood sugar level is normal.

王某,男,67 岁,2型糖尿病病史7年,现面色晦暗,乏力、口干多饮,气短、多汗,纳差,视物模糊,双下肢麻木,舌暗。舌边有齿痕,苔薄白,脉沉涩。空腹血糖11.4mmol/L,餐后2h血糖16.0mmol/L,现口服格列美脲1片,QD,二甲双胍0.5TID。在原有药物基础上给予实施例1的中药复合物,服用2个疗程后,症状减轻,继续服用1个疗程巩固,空腹血糖小于7。之后多次随访,血糖稳定在7.0mmo/L以下。Wang, male, 67 years old, with a history of type 2 diabetes for 7 years, presents with dull complexion, fatigue, dry mouth, polydipsia, shortness of breath, hyperhidrosis, anorexia, blurred vision, numbness in both lower extremities, and dark tongue. There are tooth marks on the edge of the tongue, the fur is thin and white, and the pulse is deep and astringent. Fasting blood glucose 11.4mmol/L, 2h postprandial blood glucose 16.0mmol/L, now taking 1 tablet of glimepiride, QD, metformin 0.5TID. The traditional Chinese medicine compound of Example 1 was given on the basis of the original drug. After taking 2 courses of treatment, the symptoms were relieved, and continued to take 1 course of treatment to consolidate, and the fasting blood sugar was less than 7. After several follow-up visits, the blood sugar was stable below 7.0mmo/L.

Claims (8)

1.一种降血糖的中药,其特征为,由以下重量份数的原料混合制成:黄芪30-50份、当归15-25份、葛根15-25份、茯苓15-25份、白术15-25份、木香6-15份、藿香15-25份、山药15-25份、桑叶20-40份、马齿苋15-25份、鬼箭羽15-25份、黄连8-12份、丹参15-25份、赤芍15-25份、川芎15-25份、熟地黄15-25份、麦门冬15-25份、五味子6-15份、甘草8-12份。1. A hypoglycemic Chinese medicine, characterized in that it is made by mixing the raw materials of the following parts by weight: 30-50 parts of Radix Astragali, 15-25 parts of Angelica Sinensis, 15-25 parts of Radix Puerariae, 15-25 parts of Poria cocos, 15 parts of Atractylodes macrocephala. -25 parts, woody 6-15 parts, ageratum 15-25 parts, yam 15-25 parts, mulberry leaves 20-40 parts, purslane 15-25 parts, ghost arrow feather 15-25 parts, coptis 8- 12 parts, 15-25 parts of Danshen, 15-25 parts of Radix Paeoniae Rubra, 15-25 parts of Rhizoma Chuanxiong, 15-25 parts of Rehmannia glutinosa, 15-25 parts of Ophiopogon japonicus, 6-15 parts of Schisandra, and 8-12 parts of licorice. 2.根据权利要求1所述的降血糖的中药,其特征为,由以下重量份数的原料混合制成:黄芪30-50份、当归15-25份、葛根15-25份、茯苓15-25份、白术15-25份、木香6-15份、藿香15-25份、山药15-25份、桑叶20-40份、马齿苋15-25份、鬼箭羽15-25份、黄连8-12份、丹参15-25份、赤芍15-25份、川芎15-25份、熟地黄15-25份、麦门冬15-25份、五味子6-15份、甘草8-12份。2. The Chinese medicine for hypoglycemic according to claim 1, characterized in that it is made by mixing the following raw materials in parts by weight: 30-50 parts of Radix Astragali, 15-25 parts of Angelica Sinensis, 15-25 parts of Radix Puerariae, 15-25 parts of Poria cocos. 25 parts, 15-25 parts of Atractylodes macrocephala, 6-15 parts of woody fragrance, 15-25 parts of Huoxiang, 15-25 parts of yam, 20-40 parts of mulberry leaves, 15-25 parts of purslane, 15-25 parts of ghost arrow feather 8-12 parts of Coptis chinensis, 15-25 parts of Salvia miltiorrhiza, 15-25 parts of red peony, 15-25 parts of Chuanxiong, 15-25 parts of Rehmannia glutinosa, 15-25 parts of Ophiopogon japonicus, 6-15 parts of schisandra, 8 parts of licorice -12 servings. 3.根据权利要求1所述的降血糖的中药,其特征在于:所述中药为胶囊剂。3. The Chinese medicine for lowering blood sugar according to claim 1, characterized in that: said Chinese medicine is a capsule. 4.根据权利要求1所述降血糖的中药的制备方法,其特征为,包括如下步骤:(1)分别称取各原料药,备用;(2)取党参、五味子、葛根、木香、藿香、山药、马齿苋、丹参、赤芍、熟地黄混合均匀,加水煎煮两次,过滤收集滤液后合并两次滤液,冷却后浓缩成浸膏,再烘干后粉碎成粉末,得复合物A;(2)取黄芪、当归、麦冬、桑叶、茯苓、白术、鬼箭羽、黄连、川芎、甘草,加乙醇浸泡,提取两次,合并提取液,滤过、浓缩成浸膏,干燥后粉碎,得复合物B;(4)将复合物A和复合物B混合均匀,灭菌消毒制得胶囊剂产品。4. The preparation method of the traditional Chinese medicine for hypoglycemia according to claim 1, characterized in that it comprises the following steps: (1) Weighing each raw material respectively for use; Mix incense, yam, purslane, salvia miltiorrhiza, red peony root, and rehmannia glutinosa, add water to decoct twice, collect the filtrate by filtration, combine the two filtrates, condense the filtrate after cooling, and then dry it and crush it into powder to obtain a compound Substance A; (2) Take Astragalus, Angelica, Ophiopogon japonicus, Mulberry leaves, Poria cocos, Atractylodes macrocephala, Guijianyu, Coptis rhizome, Chuanxiong, and licorice, soak in ethanol, extract twice, combine the extracts, filter, and concentrate into an extract , dried and pulverized to obtain compound B; (4) Mix compound A and compound B evenly, and sterilize to obtain a capsule product. 5.根据权利要求4所述的降血糖的中药的制备方法,其特征在于:步骤(2)中,两次煎煮中,第一次加3倍重量的水武火煮沸,然后文火煎煮1小时,过滤收集滤液和滤渣;往滤渣中添加水,以没过滤渣为准,武火煮沸,然后文火煎煮30分钟,过滤收集滤液。5. The preparation method of the traditional Chinese medicine for lowering blood sugar according to claim 4, characterized in that: in step (2), in the two decoctions, add 3 times the weight of water for the first time to boil with high fire, and then decoct with slow fire for 1 hour, filter and collect the filtrate and filter residue; add water to the filter residue, subject to no filter residue, boil with high heat, then simmer for 30 minutes, filter and collect the filtrate. 6.根据权利要求4所述的降血糖的中药的制备方法,其特征在于:步骤(2)中,滤液冷却后浓缩成密度为1.1-1.2g/mL的浸膏,80℃下烘干后,粉碎成粉末,得复合物A。6. The preparation method of the traditional Chinese medicine for lowering blood sugar according to claim 4, characterized in that: in step (2), the filtrate is cooled and concentrated into an extract with a density of 1.1-1.2g/mL, and dried at 80°C , and crushed into powder to obtain compound A. 7.根据权利要求4所述的降血糖的中药的制备方法,其特征在于:步骤(3)中,加质量浓度70%的乙醇浸泡0.5-1.5小时,提取两次,每次1-2小时,合并提取液。7. The preparation method of the traditional Chinese medicine for lowering blood sugar according to claim 4, characterized in that: in step (3), soak in ethanol with a mass concentration of 70% for 0.5-1.5 hours, extract twice, each time for 1-2 hours , combined extracts. 8.根据权利要求4所述的降血糖的中药的制备方法,其特征在于:步骤(3)中,浸膏的相对密度为1.2。8. The preparation method of the traditional Chinese medicine for lowering blood sugar according to claim 4, characterized in that: in step (3), the relative density of the extract is 1.2.
CN201810814177.3A 2018-07-23 2018-07-23 Traditional Chinese medicine for reducing blood sugar and preparation method thereof Expired - Fee Related CN108686094B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810814177.3A CN108686094B (en) 2018-07-23 2018-07-23 Traditional Chinese medicine for reducing blood sugar and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810814177.3A CN108686094B (en) 2018-07-23 2018-07-23 Traditional Chinese medicine for reducing blood sugar and preparation method thereof

Publications (2)

Publication Number Publication Date
CN108686094A true CN108686094A (en) 2018-10-23
CN108686094B CN108686094B (en) 2021-03-12

Family

ID=63851297

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810814177.3A Expired - Fee Related CN108686094B (en) 2018-07-23 2018-07-23 Traditional Chinese medicine for reducing blood sugar and preparation method thereof

Country Status (1)

Country Link
CN (1) CN108686094B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114470095A (en) * 2020-10-26 2022-05-13 郑州中一堂健康管理有限公司 Traditional Chinese medicine composition for reducing blood sugar and preparation method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101396518A (en) * 2007-09-29 2009-04-01 马万里 Traditional Chinese medicine composition for treating diabetes and complication
CN103690740A (en) * 2013-12-03 2014-04-02 刘静 Traditional Chinese medicinal formula for treating diabetes mellitus

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101396518A (en) * 2007-09-29 2009-04-01 马万里 Traditional Chinese medicine composition for treating diabetes and complication
CN103690740A (en) * 2013-12-03 2014-04-02 刘静 Traditional Chinese medicinal formula for treating diabetes mellitus

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
曲宝全等: "益气活血法治疗Ⅱ型糖尿病200例疗效观察", 《中医药学报》 *
赵健美等: "扶正活胰汤加减治疗2型糖尿病50例", 《中国中医药现代远程教育》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114470095A (en) * 2020-10-26 2022-05-13 郑州中一堂健康管理有限公司 Traditional Chinese medicine composition for reducing blood sugar and preparation method thereof

Also Published As

Publication number Publication date
CN108686094B (en) 2021-03-12

Similar Documents

Publication Publication Date Title
CN101947284B (en) Traditional Chinese medicinal composition for treating diabetes and preparation method thereof
CN106975012B (en) Traditional Chinese medicine composition for reducing blood sugar and preparation method thereof
CN104208302A (en) Fructus rosae laevigatae healthy oral solution for reducing blood fat and preparation method thereof
CN101596230B (en) Medicinal composition for treating hepatopathy
CN103948786B (en) Traditional Chinese medicine for treating diabetes
CN101411782B (en) Pharmaceutical composition for treating acute pharyngitis and preparation method thereof
CN104013845B (en) A kind of hypoglycemic Chinese medicine prepn and preparation method
CN102526498A (en) Chinese medicine for eliminating toxic and side effects after nasopharyngeal carcinoma radiotherapy and preparation method and administration way thereof
CN116870095A (en) Traditional Chinese medicine composition for treating diabetes
CN105028772B (en) Health protecting tea for blood fat reducing and preparation method thereof
CN106620475B (en) Traditional Chinese medicine composition for preventing and treating diabetes cognitive impairment and preparation method thereof
CN104107348A (en) Chinese herbal medicine for blood sugar reducing, and administration method thereof
CN102441064B (en) Traditional Chinese medicine composition and its preparation for treating diabetes
CN108686094A (en) A kind of Traditional Chinese medicine for decreasing blood sugar and preparation method thereof
CN105434738A (en) Traditional Chinese medicine composition for treating ADHD (Attention Deficit Hyperactivity Disorder) and preparation method thereof
CN104027652B (en) A kind of hypoglycemic Chinese medicine prepn and preparation method thereof
CN104644967A (en) Pharmaceutical composition for treating I-type diabetes and application thereof
CN104587175B (en) A kind of Chinese medicine preparation for treating diabetes
CN104958474A (en) Traditional Chinese medicine for treating damp heat stagnation type pancreatic cancer and preparation method thereof
CN114796417B (en) Blood sugar reducing traditional Chinese medicine formula and preparation method thereof
CN111529658A (en) A kind of ointment for treating rotavirus enteritis and preparation method
CN104258276A (en) Traditional Chinese medicine composition for treating non-alcoholic fatty liver disease and preparation method of traditional Chinese medicine composition
CN105169187B (en) A kind of composition and its application, preparation method and drug, food containing the composition
CN102205104A (en) Compound oral solution for treating infantile cough and preparation method thereof
CN105943860A (en) Medicine preparation for treating diabetes mellitus and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
TA01 Transfer of patent application right

Effective date of registration: 20210222

Address after: No.42, Wenhua West Road, Jinan City, Shandong Province

Applicant after: AFFILIATED HOSPITAL OF SHANDONG University OF TRADITIONAL CHINESE MEDICINE

Address before: Room 11a, wangdai building, Shunhua garden, Shungeng villa, Shizhong District, Jinan City, Shandong Province

Applicant before: Yin Yonghui

TA01 Transfer of patent application right
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20210312

CF01 Termination of patent right due to non-payment of annual fee